Back to GILD

GILEAD SCIENCES, INC. Deferred Revenue 2008-2017 | GILD

Beta

What is deferred revenue?

Deferred revenue represents payments received in advance for goods or services that have not yet been delivered to customers.

What is GILEAD SCIENCES, INC.'s current deferred revenue?

GILEAD SCIENCES, INC. (GILD) annual deferred revenue for 2016 was $202.0M, a 54.09% decline from 2015. GILEAD SCIENCES, INC. deferred revenue for the quarter ending March 31, 2017 was $245.0M.

What was GILEAD SCIENCES, INC.'s deferred revenue in 2015?

GILEAD SCIENCES, INC. annual deferred revenue for 2015 was $440.0M, a 228.36% increase from 2014.

What was GILEAD SCIENCES, INC.'s deferred revenue in 2014?

GILEAD SCIENCES, INC. annual deferred revenue for 2014 was $134.0M, a 20.72% increase from 2013.

What is GILEAD SCIENCES, INC.'s 5-year deferred revenue CAGR?

GILEAD SCIENCES, INC. deferred revenue grew at a compound annual growth rate (CAGR) of 22.02% from FY2011 to FY2016, going from $74.7M to $202.0M over 5 years.

Deferred Revenue History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+22.0%
FY2011
$74.7M
→
FY2016
$202.0M
080910111213141516
5 years selected
Deferred Revenue History
PeriodValueChangeSource
FY2016$202.0M-54.1%10-K
FY2015$440.0M+228.4%10-K
FY2014$134.0M+20.7%10-K
FY2013$111.0M+7.6%10-K
FY2012$103.2M+38.2%10-K
FY2011$74.7M-27.6%10-K
FY2010$103.2M-15.9%10-K
FY2009$122.7M+185.6%10-K
FY2008$43.0M-10-K
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →